Abstract:The diverse and dynamic microbial community of the human gastrointestinal tract plays a vital role in health, with gut microbiota supporting the development and function of the gut immune barrier. Crosstalk between microbiota-gut epithelium and the gut immune system determine the individual health status, and any crosstalk disturbance may lead to chronic intestinal conditions, such as inflammatory bowel diseases (IBD) and celiac disease. Microbiota-derived metabolites are crucial mediators of host-microbial interactions. Some beneficially affect host physiology such as short-chain fatty acids (SCFAs) and secondary bile acids. Also, tryptophan catabolites determine immune responses, such as through binding to the aryl hydrocarbon receptor (AhR). AhR is abundantly present at mucosal surfaces and when activated enhances intestinal epithelial barrier function as well as regulatory immune responses. Exogenous diet-derived indoles (tryptophan) are a major source of endogenous AhR ligand precursors and together with SCFAs and secondary bile acids regulate inflammation by lowering stress in epithelium and gut immunity, and in IBD, AhR expression is downregulated together with tryptophan metabolites. Here, we present an overview of host microbiota-epithelium- gut immunity crosstalk and review how microbial-derived metabolites contribute to host immune homeostasis. Also, we discuss the therapeutic potential of bacterial catabolites for IBD and celiac disease and how essential dietary components such as dietary fibers and bacterial tryptophan catabolites may contribute to intestinal and systemic homeostasis.

Short-chain fatty acids, secondary bile acids and indoles: gut microbial metabolites with effects on enteroendocrine cell function and their potential as therapies for metabolic disease

Bile Acids and Microbiota: Multifaceted and Versatile Regulators of the Liver–Gut Axis

The Influence of the Gut Microbiome on Host Metabolism Through the Regulation of Gut Hormone Release

Diet-induced metabolic changes of the human gut microbiome: importance of short-chain fatty acids, methylamines and indoles

Gut microbiota, enteroendocrine functions and metabolism

The Gut Microbial Bile Acid Modulation and its Relevance to Digestive Health and Diseases

Impact of Bacterial Metabolites on Gut Barrier Function and Host Immunity: A Focus on Bacterial Metabolism and Its Relevance for Intestinal Inflammation

Gut microbial metabolites in obesity, NAFLD and T2DM

Microbial metabolites as modulators of host physiology

The intestine as an endocrine organ and the role of gut hormones in metabolic regulation

Colonic bacterial metabolites and human health

Short-chain fatty acid receptors and gut microbiota as therapeutic targets in metabolic, immune, and neurological diseases

Messengers From the Gut: Gut Microbiota-Derived Metabolites on Host Regulation

Emerging roles of bile acids in control of intestinal functions

Consequences of bile salt biotransformations by intestinal bacteria

Bile acid metabolism and signaling, the microbiota, and metabolic disease

The Role of Short-Chain Fatty Acids and Bile Acids in Intestinal and Liver Function, Inflammation, and Carcinogenesis

Pathways and functions of gut microbiota metabolism impacting host physiology

Gut microbiota derived short-chain fatty acids in physiology and pathology: An update

The role of intestinal microbes on intestinal barrier function and host immunity from a metabolite perspective